Statement of Ownership (sc 13g)
May 30 2019 - 5:13PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G
Under
the Securities Exchange Act of 1934
Oncosec
Medical, Incorporated
|
(Name
of Issuer)
Common
Stock, $.0001 par value
|
|
(Title
of Class of Securities)
68234L207
|
(CUSIP
Number)
May
22, 2019
|
|
|
(Date
of Event Which Requires Filing of this Statement)
|
Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:
|
☐
|
Rule 13d-1(b)
|
|
|
|
|
☒
|
Rule 13d-1(c)
|
|
|
|
|
☐
|
Rule 13d-1(d)
|
*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided
in a prior cover page.
The
information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section
18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No
.
|
68234L207
|
|
Page 2 of 7
|
1
|
NAME OF REPORTING PERSONS
Altium Capital Management, LP
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
(ENTITIES ONLY) EIN: 82-2066653
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
☐
(b)
☒
|
3
|
SEC USE ONLY
|
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware, United States of America
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
5
|
SOLE VOTING
0
|
|
6
|
SHARED VOTING POWER
952,000 shares of Common Stock
714,000 shares of Common Stock issuable upon exercise of Warrants
(See Item 4) *
|
|
7
|
SOLE DISPOSITIVE POWER
0
|
|
8
|
SHARED DISPOSITIVE POWER
952,000 shares of Common Stock
714,000 shares of Common Stock issuable upon exercise of Warrants
(See Item 4) *
|
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
952,000 shares of Common Stock
714,000 shares of Common Stock issuable upon exercise of Warrants
(See Item 4) *
|
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
☐
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.99%* (See Item 4) *
|
|
12
|
TYPE OF REPORTING PERSON
IA
|
|
CUSIP No
.
|
68234L207
|
|
Page 3 of 7
|
1
|
NAME OF REPORTING PERSONS
Altium Growth Fund, LP
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
(ENTITIES ONLY) EIN: 82-2105101
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
☐
(b)
☒
|
3
|
SEC USE ONLY
|
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware, United States of America
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
5
|
SOLE VOTING
0
|
|
6
|
SHARED VOTING POWER
952,000 shares of Common Stock
714,000 shares of Common Stock issuable upon exercise of Warrants
(See Item 4) *
|
|
7
|
SOLE DISPOSITIVE POWER
0
|
|
8
|
SHARED DISPOSITIVE POWER
952,000 shares of Common Stock
714,000 shares of Common Stock issuable upon exercise of Warrants
(See Item 4) *
|
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
952,000 shares of Common Stock
714,000 shares of Common Stock issuable upon exercise of Warrants
(See Item 4) *
|
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
☐
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.99% (See Item 4) *
|
|
12
|
TYPE OF REPORTING PERSON
PN
|
|
CUSIP No
.
|
68234L207
|
|
Page 4 of 7
|
1
|
NAME OF REPORTING PERSONS
Altium Growth GP, LLC
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
(ENTITIES ONLY) EIN: 82-2086430
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
☐
(b)
☒
|
3
|
SEC USE ONLY
|
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware, United States of America
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
5
|
SOLE VOTING
0
|
|
6
|
SHARED VOTING POWER
952,000 shares of Common Stock
714,000 shares of Common Stock issuable upon exercise of Warrants
(See Item 4) *
|
|
7
|
SOLE DISPOSITIVE POWER
0
|
|
8
|
SHARED DISPOSITIVE POWER
952,000 shares of Common Stock
714,000 shares of Common Stock issuable upon exercise of Warrants
(See Item 4) *
|
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
952,000 shares of Common Stock
714,000 shares of Common Stock issuable upon exercise of Warrants
(See Item 4) *
|
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
☐
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.99% (See Item 4) *
|
|
12
|
TYPE OF REPORTING PERSON
PN
|
|
CUSIP No
.
|
68234L207
|
|
Page 5 of 7
|
Item 1(a).
|
|
Name of Issuer:
|
OncoSec Medical, Incorporated (the “Issuer”)
|
|
|
|
Item 1(b).
|
|
Address of Issuer’s Principal Executive Offices:
|
24 North Main Street
Pennington, NJ 08534
|
|
|
|
Item 2(a).
|
|
Name of Person Filing:
This statement is jointly filed by and on behalf of each of Altium
Growth Fund, LP, Altium Capital Management, LP, and Altium Growth GP, LLC. Altium Growth Fund, LP is the record and direct beneficial
owner of the securities covered by this statement. Altium Capital Management, LP is the investment adviser of, and may be deemed
to beneficially own securities, owned by, Altium Growth Fund, LP. Altium Growth GP, LLC is the general partner of, and may be deemed
to beneficially own securities owned by, Altium Growth Fund, LP.
Each reporting person declares that neither the filing of this statement
nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act
or any other purpose, the beneficial owner of any securities covered by this statement.
Each of the reporting persons may be deemed to be a member of a
group with respect to the Issuer or securities of the Issuer for the purposes of Section 13(d) or 13(g) of the Act. Each of the
reporting persons declares that neither the filing of this statement nor anything herein shall be construed as an admission that
such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, (i) acting (or has agreed or is agreeing
to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring,
holding, or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii)
a member of any group with respect to the Issuer or any securities of the Issuer.
|
|
|
|
Item 2(b).
|
|
Address of Principal Business Office or, if None, Residence:
|
|
|
The address of the principal business office of each of the reporting persons is 551 Fifth Ave, FL 19 New York, NY 10176
|
|
|
|
Item 2(c).
|
|
Citizenship:
|
|
|
See Item 4 on the cover page(s) hereto.
|
|
|
|
Item 2(d).
|
|
Title of Class of Securities:
|
|
|
Common Stock
|
|
|
|
Item 2(e).
|
|
CUSIP Number: 68234L207
|
CUSIP No
.
|
68234L207
|
|
Page 6 of 7
|
Item 3.
|
If This Statement is Filed Pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), Check Whether the Person Filing is a:
|
|
|
|
(a)
|
☐
|
Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
|
|
|
|
|
|
(b)
|
☐
|
Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
|
|
|
|
|
|
(c)
|
☐
|
Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
|
|
|
|
|
|
(d)
|
☐
|
Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
|
|
|
|
|
(e)
|
☐
|
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
|
(f)
|
☐
|
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
|
|
|
|
|
(g)
|
☐
|
A parent holding company or control person in accordance with §240.13d-1(b)(ii)(G);
|
|
|
|
|
|
(h)
|
☐
|
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
|
|
|
|
|
(i)
|
☐
|
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
|
|
|
|
|
|
(j)
|
☐
|
Group, in accordance with §240.13d-1(b)(1)(ii)(J).
|
|
|
|
|
Item 4.
|
Ownership.
|
|
|
|
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
|
|
|
|
|
The information as of the date of the event which requires filing
of this statement required by Items 4(a) – (c) is set forth in Rows 5 – 11 of the cover page for each Reporting Person
hereto and is incorporated herein by reference for each such Reporting Person. The percentage set forth in Row 11 of
the cover page for each Reporting Person is based on 10,475,073 shares of Common Stock issued and outstanding as of May 22, 2019,
as represented in the Company’s Current Form 10-Q Form filed with the Securities and Exchange Commission on May 23, 2019,
and assumes the exercise of the Company's reported warrants (the "
Reported Warrants
") and, subject to the Blockers
(as defined below)
Pursuant to the terms of the Reported Warrants, the Reporting Persons cannot exercise the Reported Warrants to the extent the Reporting
Persons would beneficially own, after any such exercise, more than 9.99% of the outstanding shares of Common Stock (the "Blocker"),
and the percentage set forth in Row 11 of the cover page for each Reporting Person gives effect to the Blocker.
CUSIP No
.
|
68234L207
|
|
Page 7 of 7
|
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
|
|
|
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following
☐
|
|
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person.
|
|
Not applicable
|
|
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
|
|
Not applicable
|
|
|
Item 8.
|
Identification and Classification of Members of the Group.
|
|
Not applicable
|
|
|
Item 9.
|
Notice of Dissolution of Group.
|
|
Not applicable
|
|
|
Item 10.
|
Certification.
|
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing
or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant
in any transaction having that purpose or effect, other than activities solely in connection with a nomination under
§
240.14a-11.
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true, complete and correct.
|
Dated:
|
May 30, 2019
|
|
|
|
|
Altium Capital Management, LP
|
|
|
|
|
By:
|
/s/ Jacob Gottlieb
|
|
Name:
|
Jacob Gottlieb
|
|
Title:
|
CEO
|
|
|
|
|
Altium Growth Fund, LP
|
|
|
|
|
By: Altium Growth GP, LLC
|
|
Its: General Partner
|
|
|
|
|
Signature:
|
/s/ Jacob Gottlieb
|
|
Name:
|
Jacob Gottlieb
|
|
Title:
|
CEO
|
|
|
|
|
Altium Growth GP, LLC
|
|
|
|
|
By:
|
/s/ Jacob Gottlieb
|
|
Name:
|
Jacob Gottlieb
|
|
Title:
|
CEO
|
OncoSec Medical (NASDAQ:ONCS)
Historical Stock Chart
From Mar 2024 to Apr 2024
OncoSec Medical (NASDAQ:ONCS)
Historical Stock Chart
From Apr 2023 to Apr 2024